Literature DB >> 31478084

Imaging of urachal anomalies.

Suryakala Buddha1, Christine O Menias2, Venkata S Katabathina3.   

Abstract

Urachal anomalies are classified into four types depending on the level of persistence of the embryonic urachal remnants between the urinary bladder and the umbilicus: patent urachus, umbilical-urachal sinus, urachal cyst, and vesico-urachal diverticulum. Due to the increasing use of cross-sectional imaging, urachal anomalies are frequently detected as incidental findings. Imaging plays a pivotal role in the initial diagnosis, evaluation of complications, treatment follow-up, and long-term surveillance of patients with urachal anomalies. Different urachal anomalies demonstrate characteristic imaging features that aid in a timely diagnosis and guide treatment. A patent urachus is visualized as an elongated tubular structure between the umbilicus and the urinary bladder. While umbilical-urachal sinus appears as focal dilatation at the umbilical end of the urachal remnant, the vesico-urachal diverticulum presents as a focal outpouching of the urinary bladder at anterosuperior aspect. Urachal cysts are identified as midline fluid-filled sacs most frequently located near the dome of the urinary bladder. Untreated urachal anomalies could progress into potential complications, including infection and malignancy. Knowledge regarding imaging features of urachal anomalies helps in timely diagnosis, treatment, follow-up, and early detection of complications.

Entities:  

Keywords:  CT; Complications; Imaging; MRI; US; Urachus

Year:  2019        PMID: 31478084     DOI: 10.1007/s00261-019-02205-x

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  2 in total

1.  Incidental vesicourachal diverticulum in a young female.

Authors:  Christopher Tan; Michael A Simon; Natalia Dolin; Lyle Gesner
Journal:  Radiol Case Rep       Date:  2020-06-20

2.  Clinical and Radiological Features of Urachal Carcinoma and Infection.

Authors:  Shichao Li; Xiaoyan Meng; Ping Liang; Cui Feng; Yaqi Shen; Daoyu Hu; Zhen Li
Journal:  Front Oncol       Date:  2021-09-07       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.